1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.
    PLEASE HELP

Cross-tolerance studies of serotonin receptors involved in behavioral effects of LSD in rats (1994)

Cross-tolerance studies of serotonin receptors involved in behavioral effects of LSD in rats (1994)

  1. Anonymous
    Psychopharmacology (Berl) 1994 Jan;113(3-4):429-37.

    Kirsten M. Krebs and Mark A. Geyer

    Like hallucinogenic 5-HT 2 agonists, LSD (d-lysergic acid diethylamide) produces characteristic decreases in locomotor activity and investigatory behaviors of rats tested in a novel environment. Because LSD is an agonist at both 5-HTIA and 5-HT 2 receptors, however, the respective influences of these different receptors in the behavioral effects of LSD remain unclear. In particular, the paucity of selective 5-HTla antagonists has made it difficult to assess the specific contribution of 5-HTIA receptors to the effects of LSD. An alternative approach to the delineation of receptor-specific effects is the use of cross-tolerance regimens. In the present studies, rats were pretreated with saline, 8-hydroxy-2(di-n-propylamino)- tetralin (8-OH-DPAT) (0.5 mg/kg SC), I-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) (1.0 mg/kg SC), or LSD (60 gg/kg SC), every 12 h for 5 or 8 days. Thirty-six hours later, rats were tested in a behavioral pattern monitor 10 rain after injection of saline, 0.5 mg/kg 8-OHDPAT, 1.0 mg/kg DOI, or 60 gg/kg LSD. As expected, tolerance to the decreases in locomotor activity produced by acute administrations of 8-OH-DPAT, DOI, or LSD occurred when rats were pretreated chronically with 8- OH-DPAT, DOI, or LSD, respectively. Furthermore, pretreatment with either 8-OH-DPAT or DOI produced cross-tolerance to LSD. These results support the hypothesis that the effects of LSD in this model reflect a combination of 5-HT1A and 5-HT 2 effects and support the view that there is an interaction between 5-HT1A and 5-HT 2 receptors.